Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 12-Month Low at $52.25

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF)’s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $52.25 and last traded at $52.25, with a volume of 0 shares changing hands. The stock had previously closed at $52.25.

Recordati Industria Chimica e Farmaceutica Stock Performance

The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average price of $52.05 and a 200 day moving average price of $51.76.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. The business had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%. Research analysts forecast that Recordati Industria Chimica e Farmaceutica S.p.A. will post 2.92 EPS for the current year.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.